Pasar al contenido principal

DESARROLLOS BASADOS EN POLIFENOLES PARA RETOS CLINICOS EN MEDICINA REGENERATIVA PENDIENTES DE RESOLVER

PID2020-114086RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Antimicrobial polymeric biomaterials based on synthetic, nanotechnology, and biotechnological approaches

  • Rojo, Luis
  • García-Fernández, Luis
  • Aguilar, María Rosa
  • Vázquez-Lasa, Blanca
Antimicrobial resistance is the main threat to biomaterial failure with a huge impact on National Health Systems and patients’ quality of life. Materials engineering and biotechnology have experienced great advances and have converged in the development of new and more sophisticated biomimetic systems with antimicrobial properties. In this sense, polymeric biomaterials play and will play a key role in the development of new antimicrobial devices for biomedical applications. In this Current Opinion article, we review recent and relevant advances reported in the field of polymeric biomaterials with antimicrobial properties with the potential to be applied in the clinic, that is, antimicrobial polymers, antifouling surfaces, nanodelivery systems of antibiotics and antiseptic drugs, biocide polymer-metal hybrid systems, and engineered living materials that actively interact with the pathogen. We conclude with a discussion on the implications of the results for clinical practice and future research., This work was supported by MICINN (Spain) (PID2020-114086RB-100). Authors are members of the SusPlast+ platform from CSIC (Spain). This research work was performed in the framework of the Nanomedicine CSIC HUB (ref 202180E048) (Spain).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The Role of Polymeric Biomaterials in the Treatment of Articular Osteoarthritis

  • Velasco-Salgado, Carmen
  • Pontes-Quero, Gloria María
  • García-Fernández, Luis
  • Aguilar, María Rosa
  • de Wit, Kyra
  • Vázquez-Lasa, Blanca
  • Rojo, Luis
  • Abradelo, Cristina
Osteoarthritis is a high-prevalence joint disease characterized by the degradation of cartilage, subchondral bone thickening, and synovitis. Due to the inability of cartilage to self-repair, regenerative medicine strategies have become highly relevant in the management of osteoarthritis. Despite the great advances in medical and pharmaceutical sciences, current therapies stay unfulfilled, due to the inability of cartilage to repair itself. Additionally, the multifactorial etiology of the disease, including endogenous genetic dysfunctions and exogenous factors in many cases, also limits the formation of new cartilage extracellular matrix or impairs the regular recruiting of chondroprogenitor cells. Hence, current strategies for osteoarthritis management involve not only analgesics, anti-inflammatory drugs, and/or viscosupplementation but also polymeric biomaterials that are able to drive native cells to heal and repair the damaged cartilage. This review updates the most relevant research on osteoarthritis management that employs polymeric biomaterials capable of restoring the viscoelastic properties of cartilage, reducing the symptomatology, and favoring adequate cartilage regeneration properties., This research was funded by the Spanish MICINN (PID2020-114086RB-100) and CIBERBBN, ISCIII, Spain. M.R.A., L.G.-F., B.V.-L. and L.R are members of the Interdisciplinary Platform SusPlast+, CSIC. This research work was performed in the framework of the Nanomedicine CSIC HUB (ref 202180E048).